Th1, Th2, and Th17 Effector Responses

Core Idea

Th1 cells produce IFN-γ to activate macrophages and enhance cell-mediated immunity against intracellular pathogens. Th2 cells produce IL-4, IL-5, and IL-13 to promote B cell antibody switching and eosinophil responses against parasites. Th17 cells produce IL-17 to recruit neutrophils and activate epithelial barriers against extracellular bacteria and fungi. Each response is optimized for specific pathogen types.

How It's Best Learned

Compare the cytokine products and target cell responses for Th1 (macrophage activation), Th2 (B cell and eosinophil responses), and Th17 (neutrophil and epithelial responses). Map which pathogen types elicit each response.

Common Misconceptions

• Th1 and Th2 responses cannot occur simultaneously (Th1/Th2 balance varies with infection, and overlap occurs). - IL-17 is exclusively produced by Th17 cells (other cells including innate lymphoid cells and γδ T cells produce IL-17).

Explainer

You already know that CD4+ helper T cells are activated when they recognize antigen presented on MHC class II molecules. But "helper T cell" is not a single cell type — it is a family of specialized effectors. When a naïve CD4+ T cell encounters antigen, the cytokine environment created by the innate immune response determines which effector lineage it differentiates into. Think of the innate response as a scout report: it tells the adaptive system what kind of threat has arrived, and the helper T cell specializes accordingly.

Th1 cells are the response to intracellular pathogens — bacteria that hide inside macrophages (like *Mycobacterium tuberculosis*) and viruses. The key polarizing cytokine is IL-12, produced by dendritic cells and macrophages that have detected intracellular infection. Once committed, Th1 cells produce IFN-γ (interferon-gamma), which supercharges macrophage killing. IFN-γ enhances the oxidative burst, upregulates MHC expression, and promotes fusion of phagosomes with lysosomes. It also drives B cells toward IgG subclasses that are effective at opsonization. In essence, Th1 responses turn macrophages from passive containers into active killing machines.

Th2 cells are the response to large extracellular parasites — helminths (worms) that are too big to phagocytose. The polarizing cytokine is IL-4, and once differentiated, Th2 cells produce IL-4, IL-5, and IL-13. IL-4 drives B cell class switching to IgE, which coats parasites and triggers mast cell degranulation. IL-5 recruits and activates eosinophils, which release toxic granule contents onto parasite surfaces. IL-13 stimulates mucus production and smooth muscle contraction in the gut, physically expelling worms. This coordinated response — antibody coating, eosinophil attack, and mucosal expulsion — is the body's anti-helminth program. Unfortunately, it is also the program that drives allergic disease when misdirected against harmless antigens.

Th17 cells are the response to extracellular bacteria and fungi at barrier surfaces — skin, gut, and lungs. Polarized by IL-6 and TGF-β, they produce IL-17 and IL-22. IL-17 is a potent neutrophil recruiter: it induces epithelial cells and fibroblasts to release chemokines that draw neutrophils to the site of infection. IL-22 strengthens epithelial barrier function and stimulates antimicrobial peptide production. Patients with defective Th17 responses suffer chronic mucocutaneous candidiasis — persistent fungal infections of the mouth, skin, and nails — demonstrating how critical this lineage is for antifungal defense at body surfaces. The three lineages are cross-regulatory: IFN-γ inhibits Th2 and Th17 differentiation, while IL-4 inhibits Th1. This mutual antagonism means the immune system generally commits to one dominant response type per infection, matching the defense strategy to the threat.